Investigating the neurochemistry of depression and the novel mood stabilising agent, ebselen, using magnetic resonance spectroscopy
RATIONALE: Magnetic resonance spectroscopy (MRS) offers a tool for investigating in vivo neurochemical changes in depression, as well as for guiding targeted drug development. Using MRS, changes to the glutamatergic system have been demonstrated in depressed patients, although results from different...
Main Author: | Masaki, Charles |
---|---|
Other Authors: | Harmer, Catherine ; Godlewska, Beata ; Cowen, Philip |
Published: |
University of Oxford
2016
|
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.729901 |
Similar Items
-
Effect of Ketamine on Human Neurochemistry in Posterior Cingulate Cortex: A Pilot Magnetic Resonance Spectroscopy Study at 3 Tesla
by: Petr Bednarik, et al.
Published: (2021-03-01) -
Neurochemistry
Published: (2014) -
Neurochemistry Predicts Convergence of Written and Spoken Language: A Proton Magnetic Resonance Spectroscopy Study of Cross-Modal Language Integration
by: Stephanie N. Del Tufo, et al.
Published: (2018-09-01) -
The Neurochemistry of Autism
by: Rosa Marotta, et al.
Published: (2020-03-01) -
Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System
by: Holly C. May, et al.
Published: (2018-03-01)